Society rejects CMSS COI code

Share this article:
The American Rhinologic Society (ARS) adopted a COI policy that permits transparent interactions between industry and ARS and its leadership.
In so doing, ARS declined to adopt the Council of Medical Specialty Society's Code for Interaction with Companies, which it said does not permit company funding and relationships. “ARS leaders believe such an extreme policy would be harmful to patients,“ noted a statement. The new policy does not set dollar amounts or limit interactions. It requires transparency—ARS said it will list relationships on its website—and creates ground rules for these relationships to prevent influence.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?